Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
about
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendationsQuantitative sensory testing measures individual pain responses in emergency department patientsPredictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study.Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.Combining Human and Rodent Genetics to Identify New Analgesics.Opioids and Chronic Pain: Where Is the Balance?Breaking barriers to novel analgesic drug development.Decreased alertness due to sleep loss increases pain sensitivity in mice.Bilateral Sensory Changes and High Burden of Disease in Patients With Chronic Pain and Unilateral Nondermatomal Somatosensory Deficits: A Quantitative Sensory Testing and Clinical Study.Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy.Is osteoarthritis one disease or a collection of many?Sensory profiling in animal models of neuropathic pain: a call for back-translation.Core outcome measurement instruments for clinical trials in nonspecific low back pain.Evaluating psychosocial contributions to chronic pain outcomes.The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain.
P2860
Q30235485-CE6F5428-878B-4DC7-B860-860253728F51Q30491945-9FF9586B-FDD5-4782-BF20-9000380E1382Q33739847-C802CB1E-94A7-49F6-90A6-DDF7DFAA75F4Q36269929-645D1331-F1B3-461B-BC0C-04D3B44259DBQ36357469-7E3342B1-7E38-4288-9C66-23AFEABA82F9Q38699127-F732328C-8AE6-4F16-B432-17BE82A4599BQ38998329-641DD477-7088-47FE-9C24-BE502FE2A9AAQ39360773-09DC51A9-26E0-4E4C-895E-8A6C8A14E0ABQ42029661-0A7A13A2-57BB-4F09-8C32-F22C1848DE38Q43061841-4DA51CD0-CDEB-454C-9800-3599108D7020Q46058628-E06432E7-DC21-48A0-81D5-7FF97447A9D3Q47266484-7B81FD3B-57DF-4029-A153-E29436C3261BQ47883719-4950825C-8417-4E6B-A011-F93D68AF9CBFQ48546193-48A9B2EA-59F8-4666-881F-50D6443A5C9AQ50166457-63DBEC19-0A39-413C-BF37-4008B05EC051Q55301721-7FD05DB3-49C2-4CE1-B370-5BD2304B9AB8
P2860
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Patient phenotyping in clinica ...... ents: IMMPACT recommendations.
@en
type
label
Patient phenotyping in clinica ...... ents: IMMPACT recommendations.
@en
prefLabel
Patient phenotyping in clinica ...... ents: IMMPACT recommendations.
@en
P2093
P2860
P50
P1433
P1476
Patient phenotyping in clinica ...... ents: IMMPACT recommendations.
@en
P2093
Amy S Chappell
Andrew S C Rice
Bob A Rappaport
Christine Veasley
Daniel Carr
Dennis C Turk
Ernest A Kopecky
George Nomikos
Jeffrey Tobias
Jennifer S Gewandter
P2860
P304
P356
10.1097/J.PAIN.0000000000000602
P407
P577
2016-09-01T00:00:00Z